PrefaceCervical cancer is the leading cause of cancer death for women in developing countries 1 . Optical technologies can improve the accuracy and availability of cervical cancer screening. For example, battery-powered digital cameras can obtain multi-spectral images of the entire cervix highlighting suspicious areas, and high-resolution optical technologies can further interrogate suspicious areas, providing in vivo diagnosis with high sensitivity and specificity. In addition, targeted contrast agents can highlight changes in biomarkers of cervical neoplasia. Such advances should provide a much needed global approach to cervical cancer prevention.
Cervical Cancer: A Global ChallengeCervical cancer is the second most common cancer in women worldwide 1 ; more than 80% of cervical cancers occur in the developing world where the least resources exist for management 1 . Most cases of cervical cancer can be prevented through screening programs, such as the Papanicolaou (Pap) smear aimed at detecting precancerous lesions for treatment. In countries in which organized programs have been established, the incidence and mortality of cervical cancer have dramatically reduced 2 . Yet, the necessary resources and infrastructure for screening are not available in many countries; as a result, 274,000 women die each year as a result of this preventable disease 1 .Cervical cancer is caused by chronic infection with high risk types of the human papilloma virus (HPV) 3 . The recent development of vaccines to prevent HPV infection promises to further reduce the incidence of cervical cancer in countries where vaccines are available 4 . However, the significant cost of vaccines and, in some cases, political or logistical barriers, could delay implementation of universal mass vaccination in many developing countries 5 . Furthermore, current vaccines are effective only against high-risk HPV types 16 and 18, which together account for approximately 70% of cervical cancers worldwide 5 . Because the vaccine does not cover all high-risk HPV subtypes, routine cervical cancer screening is still necessary, even for women who have been vaccinated, so cervical cancer screening remains necessary for the foreseeable future.
Clinical Approaches to Cervical Cancer ScreeningCurrent screening and diagnosis of cervical precancer is based on optical techniques developed in the early 1900s 2 . As shown in the top row of Fig. 1, an abnormal Pap smear is followed by examination of the cervix using a low-power light microscope (colposcope) to visualize changes in tissue reflectance, which might indicate precancer. For decades, clinical investigators have searched for ways to improve the optical contrast between normal cervix and precancerous lesions. The use of simple agents such as acetic acid and Lugol's iodine, together with the use of a green illumination filter, can highlight suspicious regions. However, because the specificity of visual examination is low, colposcopically abnormal areas are routinely biopsied to confirm the presence of disease 6 . I...